ATAD Analysis of 6 New Companies: $ACRS, $ACRX, $ACTG, $ACU, $ACY, $ADBE


For those joining in for the first time, welcome! A Ticker A Day is a format where I explore companies and decide whether to invest $10 into a stock or invest it into the $VTSAX.

After yesterday’s exploration of the ATAD Anti-Portfolio, we are back to our regular programming with analysis of six more companies. The S&P 500 declined 5.9% yesterday and is down 7.1% for the year, corrected downward 11.3% from its all time high on February 19th. This was the worst decline since March 16th, a few days after shelter in place orders went into place in states across the United States.

The ATAD portfolio did not escape yesterday’s movement unscathed:

I’m expecting a volatile day again today in the markets. I highly recommend ignoring it, and reading a good book instead. I just started reading “Gods of Jade & Shadow” by Silvia Moreno and I’m loving it. Who can resist a good myth?

Aclaris Therapeutics Inc ($ACRS)

Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs…

Upgrade to Read Full Analysis